Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

SRX-251 shows favorable safety, tolerability and pharmacokinetics in healthy subjects

June 18, 2010

Final phase II data on voreloxin/cytarabine in AML support phase III testing

June 18, 2010

Pramipexole ER shows long-term efficacy and safety in advanced Parkinson's disease

June 18, 2010

Long-term pimavanserin safe and well tolerated in Parkinson's disease psychosis

June 18, 2010

SCH-900105 is safe and advances from phase I to phase II trial

June 17, 2010

Idarubicin/busulphan improves outcome of autograft in patients with NPM1-mutant AML

June 17, 2010

GPR17 antagonist ticagrelor shows preclinical promise to treat demyelinating conditions

June 17, 2010

Endocyte presents interim phase I data on FR-targeting conjugates in solid tumors

June 17, 2010

Pridopidine beneficial in patients with Huntington's disease

June 17, 2010

Zolpidem improves limb dystonia

June 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...